Cognitive enhancement by drugs in health and disease
2011

Cognitive Enhancement by Drugs in Health and Disease

Sample size: 650 publication Evidence: moderate

Author Information

Author(s): Husain Masud, Mehta Mitul A.

Primary Institution: UCL Institute of Cognitive Neuroscience and UCL Institute of Neurology

Hypothesis

What aspects of cognition are enhanced by cognitive enhancers and what are the mechanisms underlying variations in response across individuals?

Conclusion

Experimental and clinical studies have shown that cognitive enhancers have relatively modest overall effects due to substantial variability in individual responses.

Supporting Evidence

  • Drugs like methylphenidate and modafinil are used by students and military personnel to enhance cognitive performance.
  • Clinical trials have shown that acetylcholinesterase inhibitors can improve cognitive function in patients with Alzheimer's disease.
  • Variability in response to cognitive enhancers may depend on individual differences such as baseline cognitive performance and genetic factors.

Takeaway

Some medicines can help people think better, but they don't work the same for everyone, and the improvements are usually small.

Methodology

The review discusses various studies on cognitive enhancers and their effects on cognitive functions in both healthy individuals and patients with brain disorders.

Potential Biases

Variability in individual responses may lead to biased interpretations of the effectiveness of cognitive enhancers.

Limitations

The effects of cognitive enhancers are often modest and vary widely among individuals, making it difficult to generalize findings.

Participant Demographics

The review includes studies on both healthy individuals and patients with various neurological conditions.

Digital Object Identifier (DOI)

10.1016/j.tics.2010.11.002

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication